Navigation Links
Trinity Biotech plc to Announce Third Quarter 2008 Financial Results on October 31, 2008
Date:10/23/2008

Conference Call Scheduled for October 31, 2008 at 11:00 am EASTERN

DUBLIN, Ireland, Oct. 23 /PRNewswire-FirstCall/ -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter of fiscal year 2008 on Friday, October 31, 2008. The Company has scheduled a conference call for that same day, Friday, October 31, 2008, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

USA: 1-877-356-5706

International: 1-706-679-3820

A simultaneous webcast of the call can be accessed at:

http://www.videonewswire.com/event.asp?id=52570

A replay of the call can be accessed until November 3, 2008 by dialing:

USA: 1-800-642-1687

International: 1-706-645-9291

Conference ID #: 69804141

The webcast of the call will be available for 30 days at:

http://www.videonewswire.com/event.asp?id=52570

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.

For further information please see the company's website:

http://www.trinitybiotech.com.

Contact:

Ms. Niamh Long Joe Diaz, Joe Dorame and Robert Blum

Trinity Biotech plc Lytham Partners, LLC

Investor Relations Officer 602-889-7900

(800) 603-8076


'/>"/>
SOURCE Trinity Biotech plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Trinity Biotech plc to Announce Second Quarter 2008 Financial Results on July 22, 2008
2. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
3. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
4. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
5. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
6. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
7. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
8. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
9. SourceSolution Announces the Launch of Its Initiative to Simplify Outsourcing Decisions for Biotechnology and Pharmaceutical Companies
10. Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology
11. Axial Biotech Appoints Retired Roche Diagnostics Executive to Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... 2017  Trovagene, Inc. (NASDAQ: TROV), a developer of circulating ... report financial results for the fourth quarter and year ended ... Trovagene,s senior management team will host a conference call on ... (2:00 p.m. Pacific Daylight Time) to discuss the results and ... ...
(Date:3/1/2017)... 1, 2017 Genesis Biotechnology Group (GBG), ... and research companies, announced that it has expanded ... PharmOptima. PharmOptima, a preclinical Contract ... Biodesign in the existing drug development segment of ... services, while providing the same high quality service ...
(Date:3/1/2017)... SARASOTA, Fla. , March 1, 2017  Friends, ... people living with multiple sclerosis (MS), a chronic condition ... — MSWorld , MS Views and News ... Focus: the Multiple Sclerosis Foundation — have joined ... support partners through the #MySupportHero initiative. During MS Awareness ...
(Date:3/1/2017)... ... March 01, 2017 , ... Ace Laboratories, Inc., an emerging ... announces the formation of its Scientific and Clinical Advisory Board. Ace Labs ... has been discussed in the media as “the red wine molecule”. To ...
Breaking Biology Technology:
(Date:2/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... the LEERINK Partners 6th Annual Global Healthcare Conference at ... 15, 2017 at 10 a.m. Eastern Time. ... accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will be ... Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
Breaking Biology News(10 mins):